Department of Life Science and Biotechnology
Realization of healthy longevity and sustainability
In the midst of rapid aging population and resource depletion, there is a strong need for realizing a high-quality healthy longevity society or a sustainable society that reduces environmental impact. To realize such society, we are now promoting research and development on drug discovery technology, health care technology and material production technology using bioprocess. By developing these technologies, we will contribute to the realization of world's most advanced bioeconomic society as well as Society 5.0 through sustainable material production and recycling.
 |
 |
 |
 |
 |
| Tamura Tomohiro Director General |
Miyazaki Koyomi Deputy Director General |
Aburatani Sachiyo Director, Research Planning Office |
Kim Hyonchol Director, Collaboration Promotion Office |
Kamagata Yoichi Assistant Director General |
Outline of priority strategies
● Technologies for drug discovery
To speed up drug development, we are developing technologies for rapid screening and optimization of candidate compounds. To replace time-consuming screening processes, we are developing drug design methods based on structural analysis. We have also developed the world's largest natural compound library and cancer diagnostics based on glycobiology.
● Technologies for health and medical care
To promote health and longevity, we are developing technologies for health care and medical devices which include POCT diagnostic devices for infectious diseases, POCT health checkd evices , and biocompatibility materials. To regenerate damaged tissues with stem cells, we are developing technologies for amplifying, reprogramming, and screening of stem cells which meet our high criteria.
● Technologies for bioproduction
To realize a sustainable society, we are developing fossil fuel-replacing bio-fuel, chemical raw materials, and active pharmaceutical ingredients derived from biological sources. We are exploring microorganisms and plants to produce these environment-friendly materials and refining recombinant technologies.
